Kelley Haley
Children's Hospital Los Angeles
9 Papers
25 Citations
Kelley Haley is an academic researcher from Children's Hospital Los Angeles. The author has contributed to research in topics: Head start & Induction chemotherapy. The author has an hindex of 6, co-authored 9 publications. Previous affiliations of Kelley Haley include University of British Columbia & University of Southern California.
Chat about Author
Papers
Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
Wafik Zaky,Girish Dhall,Lingyun Ji,Kelley Haley,Jeffrey C. Allen,Mark Atlas,Salvatore Bertolone,Albert Cornelius,Sharon Gardner,Ramesh Patel,Kamnesh R. Pradhan,Violet Shen,Stephen Thompson,Joseph Torkildson,Richard Sposto,Jonathan L. Finlay +15 more
TL;DR: Atypical teratoid/rhabdoid tumor (AT/RT) of the central nervous system (CNS) is a rare embryonal neoplasm of early childhood with dismal outcome and no current uniformly accepted treatment.
101
Outcome of infants and young children with newly diagnosed medulloblastoma treated on Head Start III protocol.
Girish Dhall,Lingyun Ji,Kelley Haley,J. P. Grimm,Floyd H. Gilles,Sharon Gardner,Jeffrey C. Allen,Albert Cornelius,Kamnesh R. Pradhan,James Garvin,Randal Olshefski,Juliette Hukin,Melanie Comito,Stewart Goldman,Stephen Thompson,A. Hirt,Mark Atlas,Andrew W. Walter,Richard Sposto,Jonathan L. Finlay +19 more
TL;DR: The best survival data published so far on young children with desmoplastic and anaplastic MB is reported, while avoiding craniospinal irradiation in half of the patients.
39
Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: Final report of the Head Start II and III trials
Juan Espinoza,Kelley Haley,Neha Patel,Girish Dhall,Sharon Gardner,Jeffrey C. Allen,Joseph Torkildson,Albert Cornelius,Rod Rassekh,Antranik A. Bedros,Morris Etzl,James Garvin,Kamnesh R. Pradhan,Robin Corbett,Michael J. Sullivan,Geoffrey McGowage,Dagmar T. Stein,Rama Jasty,Stephen A. Sands,Lingyun Ji,Richard Sposto,Jonathan L. Finlay +21 more
TL;DR: The final analysis of survival outcomes for children with newly diagnosed high‐grade glioma (HGG) treated on the “Head Start” (HS) II and III protocols with chemotherapy and intent to avoid irradiation in children <6 years old is reported.
35
Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the ‘Head Start’ trials, 1991–2009
C Altshuler,Kelley Haley,Girish Dhall,Laura Vasquez,Sharon Gardner,Joseph Stanek,Jonathan L. Finlay +6 more
TL;DR: Factors most likely associated with the decrease in TRM and morbidity are increasing experience with the marrow-ablative chemotherapy regimen combined with improved leukapheresis and post-reinfusion supportive care techniques, contributing toward improved overall survival.
18
P11.02 Long-term Outcome of Infants and Young Children with Newly Diagnosed Non-Nodular/Desmoplastic Medulloblastoma Treated on Head Start Iii Protocol
Girish Dhall,Lingyun Ji,Kelley Haley,Floyd H. Gilles,Sharon Gardner,Richard Sposto,Jonathan L. Finlay +6 more
TL;DR: Encouraging survival figures are reported for patients with classic medulloblastoma, similar to other contemporary infant protocols, whereas patients with LCA medullOBlastoma had equivalent survival when compared to patients withclassic medulloplastoma when treated with high-dose chemotherapy with AuHCR.